Figure 1.
A) The overall architecture of HIV-1 is shown and B) Three-dimensional structure of HIV-1 RT (p66/p51) in complex with nucleic acids is highlighted in different colors. C) A brief timeline of HIV-1 drug development and in particular the drugs identified for RT are highlighted. The two-dimensional (2D) representation of approved NNRTI drugs is depicted.